title: Cost-effectiveness of genotype-guided and dual antiplatelet therapies. In response.
authors.forename: Dhruv S
authors.initials: DS
authors.lastname: Kazi
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Owens
authors.forename: Mark A
authors.initials: MA
authors.lastname: Hlatky
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors